ArticlePerspectives in health information managemen2024
Perspectives on Big Data and Big Data Analytics in Healthcare.
Article in Perspectives in health information managemen, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reduction in Albuminuria with Dapagliflozin Exhibits Substantial Interindividual Variability: A Real-World Study Utilizing a Big Data Approach.Balkan medical journal · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Big data (BD) is of high interest for research and practice purposes because it has the potential to provide insights into the population served and healthcare practices. Much progress has been made in collecting BD and creating tools for big data analytics (BDA). However, healthcare organizations continue to experience challenges associated with BD characteristics and BDA tools. Utilization of BD impacts current decision-making, planning, and future use of artificial intelligence (AI) tools, which are trained on BD. This qualitative study focused on better understanding the reality of BD and BDA management and usage by healthcare organizations. Six structured interviews were conducted with individuals who work with healthcare BD and BDA. Findings confirmed the known challenges associated with BD/BDA and added rich insights into the structural, operational and utilization aspects, as well as future directions. Such perspectives are valuable for education and improvements in BD/BDA management and development.
Indexed as
Identifiers
40135704PMC11102055What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.